M&A activity has remained strong in 2021, building on the momentum of the second half of 2020. The “Pandemic Effect” continues to be a double-edged sword for many companies as… Read more »
Intrepid announced today that it acted as the exclusive financial advisor to Raw Sugar, LLC (Raw Sugar) on its investment from funds managed by private equity firm WM Partners LP… Read more »
Intrepid announced today that it acted as the exclusive financial advisor to Star Waggons Inc. (Star Waggons), the leading provider of luxury location trailers to the entertainment industry, on its… Read more »
Intrepid Co-Heads of Healthcare Adam Abramowitz and Jonathan Bluth are honored to accept the Los Angeles Business Journal’s award as “2021’s Trusted Advisors in Healthcare.” As leaders of the eight-person… Read more »
Ed Bagdasarian, CEO of Intrepid, recently participated in the CFO & CEO Leadership panel alongside other leading CEOs who discussed how companies could remain resilient and plan for growth in… Read more »
Investors’/buyers’ desks were flooded with investment opportunities in H1 2021, as deal activity reached record levels. Federal tax policy changes in tandem with the pandemic’s effect on prompting business owners… Read more »
Intrepid announced today that it acted as advisor to Aceto US, LLC (Aceto) on its acquisitions of A&C and Cascade Chemistry. Founded in 1947, Port Washington, N.Y.-based Aceto is a… Read more »
Intrepid announced today that it served as the exclusive financial advisor to Apostrophe, a leading teledermatology platform, on its sale to Hims & Hers Health, Inc. (NYSE: HIMS) (Hims &… Read more »
Building a company is a journey. The goal of that journey is to continuously look forward with a focus on creating and maximizing enterprise value, and to choose the optimal… Read more »